Amydis, Inc.

📍 San Diego, United States🗓 Founded 2013👥 11 employees💰 Last funded Jun 2020
Biotechnology Research🌐 amydis.com
Website LinkedIn
Amydis is leading the way for early detection of diseases through the eye that is accessible, affordable and non-invasive. The company is developing proprietary ocular tracers that enable identification of molecular biomarkers for diseases of the eye, heart and brain. Amydis is creating a data warehouse for multi-omics that includes unique molecular biomarkers of the eye to empower AI-enabled health insights. The Company’s digital health solutions leverage the eye as the “window to the body” to accelerate diagnoses, enable precision treatment and improve patient outcomes.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Amydis, Inc.?
Amydis, Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Amydis, Inc. last raise funding?
The most recent investment in Amydis, Inc. recorded on gritt.io was in June 2020.
When was Amydis, Inc. founded?
Amydis, Inc. was founded in 2013.
What industry is Amydis, Inc. in?
Amydis, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Amydis, Inc. based?
Amydis, Inc. is headquartered in San Diego, United States.